CRDL

Companies
NASDAQ
Cardiol Therapeutics Inc.
Health Care
Price Chart
Overview

About CRDL

Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases. The company's lead product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. Cardiol has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart which are a Phase II multi-national trial, the ARCHER trial, in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis.

Market Cap
$166.3M
Volume
404.3K
Avg. Volume
347.2K
P/E Ratio
-2.7419355
Dividend Yield
0.00%
Employees
18.0

Company Information

Exchange
NASDAQ
Sector
Health Care
Industry
Drug Manufacturers - Specialty & Generic
Risk & Correlation Analysis
Market Correlation
1.17
Moderate Correlation
Volatility
High (0.75)
Relative to market

Macro Factor Sensitivities

Interest Rates
Medium Sensitivity
Inflation
Medium Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
Medium Sensitivity
Portfolio Impact
Forecasts & Predictions

Premium Forecasts

Get AI-powered price predictions, technical analysis, and market forecasts for CRDL.

1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential

Technical Analysis

Based on technical indicators and chart patterns, CRDL shows...

AI Sentiment Analysis

Market sentiment analysis indicates...

Key Statistics
Market Cap$166.3M
Volume404.3K
P/E Ratio-2.74
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
April 2, 2025

PortfolioPilot Analysis

Get AI-powered insights on how CRDL fits into your investment strategy and portfolio diversification.

Pricing info last updated June 19, 2025 (after market close)Other info last updated April 2, 2025